NCT03996460View on ClinicalTrials.gov

K0706 for Patients Diagnosed With Dementia With Lewy Bodies

PHASE2RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

June 30, 2023

Study Completion Date

October 31, 2023

Conditions
Dementia With Lewy Bodies
Interventions
DRUG

Placebo

"Fifteen (15) patients in group 1 will receive the sachet of matching placebo ( equivalent to a capsule of placebosugar pill) orally daily for 12 weeks (90 days) without food."

DRUG

192 mg powder of K0706

Fifteen (15) patients in group 2 will receive the sachet of 192 mg powder of K0706 ( equivalent to 96 mg capsule of K0706) orally for 12 weeks (90 days) without food.

DRUG

384 mg powder of K0706

Fifteen (15) patients in group 3 will receive the 384 mg powder of K0706 (equivalent to 192 capsule of K0706) orally daily for 12 weeks (90 days) without food.

Trial Locations (1)

20007

RECRUITING

MedStar Georgetown University Hospital, Washington D.C.

All Listed Sponsors
collaborator

Sun Pharma Advanced Research Company Limited

INDUSTRY

lead

Georgetown University

OTHER